您好,欢迎来到易推广 请登录 免费注册

MedChemExpress 主营产品:Medchemexpress,抑制剂专家,生物试剂公司

易推广认证请放心拨打

021-58955995

当前位置: 易推广 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > MedChemExpress > 产品展示 > MCE信号通路 > 细胞周期/DNA 损伤 > Retaspimycin Hydrochloride

提示:信息由商家自行发布,信息的真伪性请消费者自己判断,信息内容的准确性由相关商家负责,易推广对此不承担任何责任。

Retaspimycin Hydrochloride

价格:¥电议

品牌名称:$brandModel.Title(进口品牌)型号: 原产地:美洲 发布时间:2021/7/24更新时间:2024/6/12

产品摘要:Retaspimycin Hydrochloride是有效的 Hsp90 抑制剂,EC50 为119 nM。

产品完善度: 访问次数:1594

企业档案

会员类型:会员

已获得易推广信誉   等级评定
171成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

易推广会员:8

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

企业类型:生产商 【已认证】

注册资金:人民币万 【已认证】

产品数:91228

参观次数:11307048

手机网站:http://m.yituig.com/c131527/

旗舰版地址:http://medchemexpress.app17.com

联系我们

MedChemExpress

电话:021-58955995

联系人:客服部 (请说明是在易推广看到的!谢谢)

手机:13611715263

邮编:201203

邮箱:sales@medchemexpress.cn

地址:上海上海

详细内容

联系方式:
电话:021-58955995 手机:13611715263 联系人:客服部   Q Q:4008203792

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

Retaspimycin Hydrochloride

CAS No. : 857402-63-2

MCE 站:Retaspimycin Hydrochloride

产品活性:Retaspimycin Hydrochloride是有效的 Hsp90 抑制剂,EC50 为119 nM。

研究领域:Cell Cycle/DNA Damage  |  Metabolic Enzyme/Protease

作用靶点:HSP

In Vitro: Retaspimycin (IPI-504) is a novel and highly soluble analog of 17AAG, an inhibitor of Hsp90. Retaspimycin can abrogate both the unfolded protein response element (UPRE) and ERSE-driven luciferase activity in non-treated U266 and MM.1s cells as well as in Tunicamycin (Tm)-treated cells. The IC50s for the inhibition of reporter gene activity by Retaspimycin are 196±56 nM in U266 and 472±177 nM in MM.1s for UPRE-luc activity and 213±140 nM for the ERSE-driven activity in MM.1s cells. Retaspimycin treatment leads to a dose-dependent decrease of p50ATF6 with EC50 of 237 nM, consistent with the reporter-gene assay. The level of sXBP1 is decreased in the presence of Retaspimycin with an apparent EC50 between 300 nM and 1 μM. Incubation of Retaspimycin (IPI-504) potently suppresses both Akt and MAPKs phosphorylation in both sensitive and Trastuzumab-resistant cells. Total levels of Akt decreased in all 4 cell lines (BT474, SKBR-3, HCC1569, and HCC1569) in a dose-dependent manner. However, levels of total MAPKs are not significantly altered with Retaspimycin treatment.

In Vivo: Retaspimycin (IPI-504) and Trastuzumab independently induce tumor regression of Trastuzumab-sensitive BT474 cell-derived xenografts. Xenografts derived from BT474R cells continue to grow in the presence of Trastuzumab but are still sensitive to Retaspimycin. When used in combination, Retaspimycin and Trastuzumab add only marginal benefits to Retaspimycin monotherapy. Retaspimycin (100 mg/kg) as a single agent is more efficacious than Trastuzumab in inhibiting tumor growth in HCC1569 xenografts. The combination is not significantly superior to Retaspimycin used as a single agent.

相关产品:Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Endoplasmic Reticulum Stress Compound Library  |  Pyroptosis Compound Library  |  Cytoskeleton Compound Library  |  Tamoxifen  |  Tanespimycin  |  Geldanamycin  |  Palmitic acid  |  Rocaglamide  |  VER-155008  |  Arimoclomol maleate  |  PU-WS13  |  Pifithrin-μ  |  MKT-077  |  KNK437  |  KRIBB11  |  Paeoniflorin  |  TRC051384  |  ML346  |  Radicicol  |  Tepre  |  AMP-PCP disodium  |  Ethoxyquin  |  Cucurbitacin D  |  Falcarinol  |  Aminohexylgeldanamycin  |  HS-27  |  3-Phenyltoxoflavin  |  Alvespimycin  |  Calenduloside E  |  Geldanamycin-FITC  |  Kongensin A  |  10,11-Dehydrocurvularin

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物;
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
•   设有专业的实验中心和严格的质控、验证体系;
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
•   产品的生物活性多经各国客户实验验证;
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
•   专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
•   与世界各大制药公司及知名科研机构建立了长期的合作。

1000+ Inhibitors&Agonists 作用于20多条经典信号通路
30+ Screening Libraries 疾病机制研究的高效工具
CCK8 Kit | Cell Counting Kit-8
FDA-Approved 药物筛选库
Inhibitor Cocktails 蛋白酶, 磷酸酶 & 去乙酰化酶
Top Publications Citing Use of MCE
MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持
联系方式:
电话:021-58955995 手机:13611715263 联系人:客服部   Q Q:4008203792

热门标签:IPI-504 

快速导航

在线咨询

提交